Back to ALCView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Allergic Conjunctivitis
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA5/16/2002
Opatanol
Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
Difluprednate 0.05% ophthalmic emulsionPhase 3
Endogenous Anterior Uveitis
Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solutionPhase 3
Glaucoma, Open-angle
Ofloxacin otic solutionPhase 3
Acute Otitis Media
AL-4943A ophthalmic solutionPhase 3
Allergic Conjunctivitis
Brinzolamide 1% ophthalmic suspensionPhase 3
Open-Angle Glaucoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts